{"id":"https://genegraph.clinicalgenome.org/r/5c06a8e7-cc80-45d3-b620-c6bdc13a034av1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the ERCC3 gene with xeroderma pigmentosum group B since the gene-disease relationship was first proposed by Weeda et al. (1990). Multiple case level studies have been performed with XPB patients that have variants in the ERCC3 gene. Although germline ERCC3 variants are rare, eight known disease-causing mutations from six patients have been reported to date. 8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway were reported to cause Xeroderma Pigmentosum. Studies of patient-derived cells showed decreased DNA repair rates and decreased levels of XPB protein. An Xpb mouse model for combined xeroderma pigmentosum and cockayne syndrome has been established to show consistent phenotypes with XPB patients by recapitulating the UV sensitivity. All of these types of evidence are consistent with a definitive relationship between the ERCC3 gene and xeroderma pigmentosum group B.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5c06a8e7-cc80-45d3-b620-c6bdc13a034a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2019-04-19T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/999ee5bf-b21c-4a13-9d02-b2ed95989c46","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c66c1d9d-a6c0-443f-948e-573e853228d1","type":"Finding","dc:description":"Severe alterations in Xpb cause embryonic lethality and knock-in mice closely mimicking an XPCS patient-derived XPB mutation recapitulate the UV sensitivity typical for XP but fail to show overt CS features unless the DNA repair capacity is further challenged by crossings to the NER-deficient Xpa background.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19114557","rdfs:label":"An Xpb Mouse Model for Xeroderma Pigmentosum and CS","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/052dd654-9b94-43dc-846e-ba44a353abfc","type":"EvidenceLine","dc:description":"Increase points because four assays (DNA Repair, Post-UV Cell Viability, Post-UV RNA Synthesis Recovery, and XPB Protein Levels) were preformed using patient-derived cells from five XPB patients (XP11BE, XP33BR, XPCS1BA, XP131MA, and XP183MA).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef12cd52-d90d-467c-9db6-3d1d774a0f79","type":"FunctionalAlteration","dc:description":"Reduced DNA Repair, Post-UV Cell Viability, Post-UV RNA Synthesis Recovery, and XPB Protein Levels of XP-B Cells (XP11BE, XP33BR, XPCS1BA, XP131MA, and XP183MA).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","rdfs:label":"Patient cells show decreased DNA repair rate and XPB protein"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94a295fe-ee9c-4bfb-ba50-bd33ca13dffc","type":"EvidenceLine","dc:description":"Eight genes","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7f23a30-7699-4b60-9a6a-12b24a7657ce","type":"Finding","dc:description":"8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway cause Xeroderma Pigmentosum.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24105368","rdfs:label":"8 complementation groups genes cause Xeroderma Pigmentosum","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fbd9939-a032-4434-ad2c-f451dcabecd1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A heterozygous G-to-A transition at the +1 position of intron 3 (IVS3DS+1G-A) of the ERCC3 gene, resulting in premature termination of the protein at codon 162. These brothers had been shown by Vermeulen et al. (1994) to also have a heterozygous mutation in the ERCC3 gene (F99S).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fa7829b-6729-4d01-9a07-18cc69647235","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","rdfs:label":"XPCS1BA","ageType":"AgeAtReport","ageUnit":"Years","ageValue":38,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0004322","obo:HP_0000407","obo:HP_0001347"],"previousTesting":true,"previousTestingDescription":"Scott et al., 1993; Vermeulen et al., 1994","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6fbd9939-a032-4434-ad2c-f451dcabecd1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d6eb3a7b-07e4-43c8-a3bf-381085466344","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000122.1(ERCC3):c.296T>C (p.Phe99Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16583"}},{"id":"https://genegraph.clinicalgenome.org/r/57c86a2a-d520-47a9-8ff6-3f18838ea81b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ERCC3, IVS3DS, G-A, +1","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16589"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d6863264-041e-412e-8fc8-564e39eaadfc_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations in the ERCC3 gene: a 296T-C transition in exon 3 of the ERCC3 gene, resulting in an F99S substitution, and a 1273C-T transition in exon 8, resulting in an arg425-to-ter (R425X) substitution. Studies of patient-derived cells showed decreased DNA repair rates and decreased levels of XPB protein.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/821200a4-9cca-46a2-a6c0-af65fb292bf5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","rdfs:label":"XP33BR","ageType":"AgeAtReport","ageUnit":"Years","ageValue":44,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0008619","obo:HP_0002671","obo:HP_0002861","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d6863264-041e-412e-8fc8-564e39eaadfc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d6eb3a7b-07e4-43c8-a3bf-381085466344"},{"id":"https://genegraph.clinicalgenome.org/r/1b68d543-b1da-446b-81a3-f7450a6295af","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000122.1(ERCC3):c.1273C>T (p.Arg425Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16585"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/941b7ecc-5e53-4da8-8fe0-019dfbd76418_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6d62e20-5e43-4f8f-bac4-a805efdd39f5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26884178","rdfs:label":"XP84BR","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":28,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000407","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/941b7ecc-5e53-4da8-8fe0-019dfbd76418_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26884178","allele":{"id":"https://genegraph.clinicalgenome.org/r/d6eb3a7b-07e4-43c8-a3bf-381085466344"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d7b2927e-7925-4d1e-a9c9-ae22489d9db0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations in the ERCC3 gene: a splice site mutation and a 2-bp deletion (807delTT). Hwang et al. (1996) performed detailed in vitro studies of the splicing mutant XPB protein. It showed decreased 3-prime to 5-prime XPB helicase activity and decreased DNA-dependent ATPase activities, resulting in a severe DNA nucleotide excision repair (NER) defect (5-10% of wildtype). There was also evidence for a decrease in basal transcription activity.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0322d5cf-9325-4abf-9ac0-50ec44df9c6e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2167179","rdfs:label":"XP11BE","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":33,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0000568","obo:HP_0008873","obo:HP_0000399","obo:HP_0005328","obo:HP_0010864","obo:HP_0000252","obo:HP_0008069"],"previousTesting":true,"previousTestingDescription":"Robbins et al. (1974)","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d7b2927e-7925-4d1e-a9c9-ae22489d9db0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2167179","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ea86c2c5-f4c2-492d-9ecf-0c4f1e10cf1c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ERCC3, 2-BP DEL, 807TT","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16586"}},{"id":"https://genegraph.clinicalgenome.org/r/ca3aa7e7-c3bb-4ea6-af6b-85b0f2c3f23d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ERCC3, IVS14AS, C-A, -6","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16582"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3fa3f9d6-7d75-466c-981c-b195abe753a2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A C-to-A transversion in the splice acceptor sequence of intron 14 of ERCC3 and a 1-bp insertion (1421insA) in exon 9, resulting in a frameshift and premature termination of the protein at codon 475.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d913ab6-ca1e-430f-9f0a-bf509b29aca9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","rdfs:label":"XP131MA","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001272","obo:HP_0000648","obo:HP_0007380","obo:HP_0000992","obo:HP_0000407","obo:HP_0002860","obo:HP_0000580"],"previousTesting":true,"previousTestingDescription":"Bartenjev et al., 2000","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3fa3f9d6-7d75-466c-981c-b195abe753a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d5b62476-ad9d-4d37-8032-e37a40354c0f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ERCC3, 1-BP INS, 1421A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16587"}},{"id":"https://genegraph.clinicalgenome.org/r/ca3aa7e7-c3bb-4ea6-af6b-85b0f2c3f23d"}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bf09deab-9612-4b13-8bb7-4c2a25dde868_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d451576d-62e1-4a81-8c17-d5f77e065466_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","rdfs:label":"XP33BR and XP1SA","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/d451576d-62e1-4a81-8c17-d5f77e065466","type":"Family","rdfs:label":"XP33BR and XP1SA","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/821200a4-9cca-46a2-a6c0-af65fb292bf5"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002671","obo:HP_0008619","obo:HP_0002861","obo:HP_0000992"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/821200a4-9cca-46a2-a6c0-af65fb292bf5"}},{"id":"https://genegraph.clinicalgenome.org/r/1f2040d0-561d-41a1-bd26-1a7037223e82_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","rdfs:label":"XPCS1BA and XPCS2BA","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/1f2040d0-561d-41a1-bd26-1a7037223e82","type":"Family","rdfs:label":"XPCS1BA and XPCS2BA","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6fa7829b-6729-4d01-9a07-18cc69647235"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001347","obo:HP_0000992","obo:HP_0000407","obo:HP_0004322"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6fa7829b-6729-4d01-9a07-18cc69647235"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bd4399a9-4c88-4fe2-9b25-d1e4373d28fc_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations in the ERCC3 gene: a splice site mutation (C-to-A transversion in the splice acceptor sequence of intron 14 of ERCC3) and a 1633C-T transition in exon 10, resulting in a gln545-to-ter (Q545X) substitution.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99e27bbf-8030-4d28-96ba-a91bfd1fc30a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","rdfs:label":"XP183MA","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0002066","obo:HP_0000407","obo:HP_0000540","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/bd4399a9-4c88-4fe2-9b25-d1e4373d28fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16947863","allele":[{"id":"https://genegraph.clinicalgenome.org/r/33cf45ad-cdec-41d7-9453-003cceba62a7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000122.1(ERCC3):c.1633C>T (p.Gln545Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16588"}},{"id":"https://genegraph.clinicalgenome.org/r/ca3aa7e7-c3bb-4ea6-af6b-85b0f2c3f23d"}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11}],"evidenceStrength":"Definitive","sequence":431,"specifiedBy":"GeneValidityCriteria6","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/CkQCq2_no1w","type":"GeneValidityProposition","disease":"obo:MONDO_0012531","gene":"hgnc:3435","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_bf09deab-9612-4b13-8bb7-4c2a25dde868-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}